TI
COLL icon

Trexquant Investment’s Collegium Pharmaceutical COLL Stock Holding History

Trexquant Investment’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Sell
68,114
-82,488
-55% -$3.49M 0.02% 951
2025
Q4 		$6.97M Buy
+150,602
New +$6.3M 0.06% 435
2024
Q3 		– Sell
-15,806
Closed -$509K – 1570
2024
Q2 		$509K Sell
15,806
-92,421
-85% -$3.2M 0.01% 1242
2024
Q1 		$4.2M Buy
108,227
+13,650
+14% +$478K 0.08% 370
2023
Q4 		$2.91M Sell
94,577
-38,402
-29% -$962K 0.07% 432
2023
Q3 		$2.97M Buy
132,979
+32,680
+33% +$745K 0.07% 370
2023
Q2 		$2.16M Sell
100,299
-15,428
-13% -$350K 0.06% 472
2023
Q1 		$2.78M Buy
115,727
+105,323
+1,012% +$2.79M 0.08% 349
2022
Q4 		$241K Buy
+10,404
New +$210K 0.01% 1177
2021
Q4 		– Sell
-18,549
Closed -$366K – 1348
2021
Q3 		$366K Buy
+18,549
New +$401K 0.03% 660
2021
Q2 		– Sell
-20,174
Closed -$478K – 1147
2021
Q1 		$478K Buy
+20,174
New +$479K 0.04% 527
2019
Q3 		– Sell
-11,316
Closed -$149K – 895
2019
Q2 		$149K Sell
11,316
-18,669
-62% -$250K 0.01% 714
2019
Q1 		$454K Sell
29,985
-3,096
-9% -$49.6K 0.03% 606
2018
Q4 		$568K Sell
33,081
-1,111
-3% -$19K 0.04% 577
2018
Q3 		$504K Buy
+34,192
New +$606K 0.04% 536
2018
Q2 		– Sell
-23,534
Closed -$601K – 945
2018
Q1 		$601K Buy
+23,534
New +$561K 0.04% 579
2017
Q2 		– Sell
-25,705
Closed -$259K – 837
2017
Q1 		$259K Buy
+25,705
New +$382K 0.03% 835

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Trexquant Investment's COLL Position: Q1 2026 in Review

Trexquant Investment reduced its Collegium Pharmaceutical (COLL) stake by 55% in Q1 2026, selling an estimated $3.49M and leaving 68,114 shares worth $2.25M. The position accounts for 0.02% of the portfolio, ranked #951.

Trexquant Investment first reported a position in COLL in Q1 2017 and has held it in 17 quarters since. The position peaked at $6.97M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Trexquant Investment held 68,114 shares of Collegium Pharmaceutical worth $2.25M as of Q1 2026.
  • Trexquant Investment sold 82,488 Collegium Pharmaceutical shares in Q1 2026, an estimated $3.49M.
  • Collegium Pharmaceutical made up 0.02% of Trexquant Investment's portfolio in Q1 2026, its #951 holding.
  • Trexquant Investment first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 17 quarters since.
  • Trexquant Investment's Collegium Pharmaceutical position peaked at $6.97M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.